Stock listing
NASDAQ:SCMP Sucampo Pharmaceuticals Inc Stock
Follow Sucampo Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:SCMP
$18.00 USD
Close on Feb 13, 2018 · No longer trades
- Lowest – highest close
- $2.84 – $28.96 USDSince Aug 2, 2007 · lowest Dec 15, 2008 · highest Sep 17, 2015
Delisted NASDAQ:SCMP no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:SCMP
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Sucampo Pharmaceuticals Inc on 6ix
- Decks
- 77 decks · latest Nov 16, 2017
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Day (November 2017) | Investor day | 100 slides | Nov 16, 2017 |
| Q3 2017 Earnings Presentation | Earnings | 28 slides | Nov 1, 2017 |
| Cantor Fitzgerald Global Healthcare Conference 2017 | Conference | 22 slides | Sep 26, 2017 |
| Q2 2017 Earnings Presentation | Earnings | 28 slides | Aug 2, 2017 |
| Q1 2017 Earnings Presentation | Earnings | 24 slides | May 3, 2017 |
| Merger or Acquisition (April 2017) | Merger or acquisition | 15 slides | Apr 3, 2017 |
| 29th Annual ROTH Conference 2017 | Conference | 22 slides | Mar 13, 2017 |
| Q4 2016 Earnings Presentation | Earnings | 29 slides | Mar 8, 2017 |
| Corporate Update (January 2017) | Corporate update | 22 slides | Jan 9, 2017 |
| Debt Investor Presentation (December 2016) | Debt investors | 22 slides | Dec 19, 2016 |
Show 50 decks
This page holds 50 of 77 decks. Open Decks
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| John H. Johnson Other companies: Xeris Biopharma Holdings, Inc. (Independent, Non-executive Board Member · Since at least Oct 5, 2021); Axogen, Inc. (Director · Since at least Jul 19, 2021); Verastem, Inc. (Member, Compensation Committee; Member, Nominating and Corporate Governance Committee · Since at least Apr 23, 2020); Applied Therapeutics Inc (Executive Chairman, Director · Dec 19, 2024 – Dec 19, 2024 · Past); Melinta Therapeutics Inc (Chief Executive Officer, Director · Jun 12, 2018 – Jun 27, 2019 · Past); AVEO Pharmaceuticals Inc (Director · Feb 1, 2018 – Feb 1, 2018 · Past); Strongbridge Biopharma plc (Chief Executive Officer, Director · Jan 1, 2018 – Oct 5, 2021 · Past); Cempra Inc (Director · Jan 3, 2017 – Jan 3, 2017 · Past); Ocugen, Inc. (Director · Dec 16, 2016 – Jun 15, 2018 · Past); Portola Pharmaceuticals Inc (Director · Jun 17, 2016 – Jul 2, 2020 · Past) | Director · Jun 2, 2016 – Feb 13, 2018 · Past |
| Karen Smith Other companies: Context Therapeutics Inc. (Independent Director · Since at least Sep 4, 2024); Skye Bioscience, Inc. (Director · Since at least Jul 2, 2024); Sangamo Therapeutics, Inc. (Director · Since at least Jun 26, 2018); Aurinia Pharmaceuticals Inc (Director · Aug 18, 2023 – Nov 21, 2024 · Past); Quince Therapeutics, Inc. (Chief Medical Officer · May 19, 2022 – Feb 1, 2023 · Past); Tourmaline Bio Inc. (Director · May 16, 2022 – Jun 13, 2023 · Past); Emergent BioSolutions Inc. (EVP, Chief Medical Officer · May 21, 2020 – May 7, 2021 · Past); Antares Pharma Inc (Director · Mar 1, 2019 – May 24, 2022 · Past); Acceleron Pharma Inc (Director · Nov 15, 2017 – Nov 19, 2021 · Past); Jazz Pharmaceuticals plc (EVP, R&D and CMO · Apr 13, 2015 – Mar 5, 2018 · Past) | Director · Jul 15, 2017 – Feb 13, 2018 · Past |
| Robert J. Spiegel Other companies: Ernexa Therapeutics Inc. (Director · Since at least Sep 14, 2026); RenovoRx, Inc. (Director · Since at least Apr 25, 2023); Geron Corporation (Director · Since at least Sep 29, 2017); Athenex Inc (Director · Aug 4, 2020 – Apr 21, 2023 · Past); Ayala Pharmaceuticals Inc (Director · May 7, 2020 – Jan 19, 2023 · Past); Bio Green Med Solution, Inc. (Director · Sep 6, 2018 – Jun 30, 2023 · Past); PDS Biotechnology Corporation (Director · Jun 19, 2018 – Mar 15, 2019 · Past) | Director · Feb 13, 2018 – Feb 13, 2018 · Past |
| Peter Greenleaf Other companies: Pelthos Therapeutics Inc. (Chairman · Since at least Jul 1, 2025); Aurinia Pharmaceuticals Inc (Chief Executive Officer, Director · Since at least Jan 1, 2021); Antares Pharma Inc (Director · Dec 12, 2018 – May 24, 2022 · Past); Kiora Pharmaceuticals, Inc. (Director · Jul 10, 2018 – Feb 1, 2019 · Past); BioDelivery Sciences International Inc (Director · May 21, 2018 – Mar 22, 2022 · Past); Avalo Therapeutics, Inc. (Director · Mar 27, 2018 – Aug 7, 2019 · Past) | Chief Executive Officer · Sep 30, 2017 – Feb 13, 2018 · Past |
| Peter P Pfreundschuh Other companies: Y mAbs Therapeutics (EVP, CFO and Treasurer · Since at least Jun 28, 2024); Voyager Therapeutics, Inc. (Chief Financial Officer · Sep 19, 2022 – Feb 21, 2024 · Past); Korro Bio, Inc. (Chief Financial Officer · Dec 1, 2020 – Feb 18, 2022 · Past); UroGen Pharma Ltd. (Chief Financial Officer · Jan 1, 2019 – Oct 15, 2020 · Past); Immunomedics Inc (Chief Financial Officer · Aug 20, 2015 – Aug 20, 2015 · Past) | CFO · Mar 20, 2017 – Feb 13, 2018 · Past |
| Matthew Maxwell Donley Other companies: Aurinia Pharmaceuticals Inc (Chief Operating Officer · Since at least Jan 1, 2021) | EVP, Global HR, IT & Strategy · Mar 4, 2015 – Feb 13, 2018 · Past |
| Jones W Bryan | Sr. Vice Pres., BD & Licensing · Dec 31, 2017 – Feb 13, 2018 · Past |
Log in to ask 6ix AI your own questions about Sucampo Pharmaceuticals Inc.